Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline
- Author
- AZZIZ, Ricardo1 ; CARMINA, Enrico2 ; WITCHEL, Selma F11 ; DEWAILLY, Didier3 ; DIAMANTI-KANDARAKIS, Evanthia4 ; ESCOBAR-MORREALE, Hector F5 ; FUTTERWEIT, Walter6 ; JANSSEN, Onno E7 ; LEGRO, Richard S8 ; NORMAN, Robert J9 ; TAYLOR, Ann E10
[1] Cedars-Sinai Medical Center and The David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90048, United States
[2] University of Palermo, 90128 Palermo, Italy
[3] Lille University Hospital, 59037 Lille, France
[4] University of Athens Medical School, 157 84 Athens, Greece
[5] Hospital Ramon y Cajal and University of Alcald, 28801 Madrid, Spain
[6] Mount Sinai School of Medicine, New York, New York 10029, United States
[7] University of Essen, 45131 Essen, Germany
[8] Pennsylvania State University School of Medicine, Hershey, Pennsylvania 17033, United States
[9] University of Adelaide, Woodville, South Australia 5005, Australia
[10] Pfizer Global Research and Development, Groton, Connecticut 06340, United States
[11] Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States - Source
The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 11, pp 4237-4245, 9 p ; ref : 97 ref
- CODEN
- JCEMAZ
- ISSN
- 0021-972X
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- Endocrine Society, Bethesda, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Androgène Endocrinologie Hyperandrogénie Ovaire polykystique Recommandation Société Appareil génital femelle pathologie Endocrinopathie Hormone stéroïde sexuelle Kyste Ovaire pathologie Stérilité femelle Tumeur bénigne
- Keyword (en)
- Androgen Endocrinology Hyperandrogenism Polycystic ovary Recommendation Society Female genital diseases Endocrinopathy Sex steroid hormone Cyst Ovarian diseases Female sterility Benign neoplasm
- Keyword (es)
- Andrógeno Endocrinología Hiperandrogenismo Ovario poliquístico Recomendación Sociedad Aparato genital hembra patología Endocrinopatía Hormona esteroide sexual Quiste Ovario patología Esterilidad femenina Tumor benigno
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A28 Vertebrates: endocrinology
- Discipline
- Endocrinopathies Vertebrates : endocrinology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18274595
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1210/jc.2006-0178 
https://dx.doi.org/10.1210/jc.2006-0178
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2006-0178\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4237\";s:8:\"\u0000*\u0000epage\";s:4:\"4245\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZZIZ\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ricardo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"CARMINA, Enrico\";i:1;s:16:\"WITCHEL, Selma F\";i:2;s:16:\"DEWAILLY, Didier\";i:3;s:29:\"DIAMANTI-KANDARAKIS, Evanthia\";i:4;s:26:\"ESCOBAR-MORREALE, Hector F\";i:5;s:18:\"FUTTERWEIT, Walter\";i:6;s:15:\"JANSSEN, Onno E\";i:7;s:16:\"LEGRO, Richard S\";i:8;s:16:\"NORMAN, Robert J\";i:9;s:13:\"TAYLOR, Ann E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2006-0178\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4237\";s:8:\"\u0000*\u0000epage\";s:4:\"4245\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZZIZ\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ricardo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"CARMINA, Enrico\";i:1;s:16:\"WITCHEL, Selma F\";i:2;s:16:\"DEWAILLY, Didier\";i:3;s:29:\"DIAMANTI-KANDARAKIS, Evanthia\";i:4;s:26:\"ESCOBAR-MORREALE, Hector F\";i:5;s:18:\"FUTTERWEIT, Walter\";i:6;s:15:\"JANSSEN, Onno E\";i:7;s:16:\"LEGRO, Richard S\";i:8;s:16:\"NORMAN, Robert J\";i:9;s:13:\"TAYLOR, Ann E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2006-0178\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2006-0178\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4237\";s:8:\"\u0000*\u0000epage\";s:4:\"4245\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZZIZ\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ricardo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"CARMINA, Enrico\";i:1;s:16:\"WITCHEL, Selma F\";i:2;s:16:\"DEWAILLY, Didier\";i:3;s:29:\"DIAMANTI-KANDARAKIS, Evanthia\";i:4;s:26:\"ESCOBAR-MORREALE, Hector F\";i:5;s:18:\"FUTTERWEIT, Walter\";i:6;s:15:\"JANSSEN, Onno E\";i:7;s:16:\"LEGRO, Richard S\";i:8;s:16:\"NORMAN, Robert J\";i:9;s:13:\"TAYLOR, Ann E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1210\/jc.2006-0178\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:9:\"\u0000*\u0000jtitle\";s:52:\"The Journal of clinical endocrinology and metabolism\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. clin. endocrinol. metab\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"91\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4237\";s:8:\"\u0000*\u0000epage\";s:4:\"4245\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0021-972X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZZIZ\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Ricardo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"CARMINA, Enrico\";i:1;s:16:\"WITCHEL, Selma F\";i:2;s:16:\"DEWAILLY, Didier\";i:3;s:29:\"DIAMANTI-KANDARAKIS, Evanthia\";i:4;s:26:\"ESCOBAR-MORREALE, Hector F\";i:5;s:18:\"FUTTERWEIT, Walter\";i:6;s:15:\"JANSSEN, Onno E\";i:7;s:16:\"LEGRO, Richard S\";i:8;s:16:\"NORMAN, Robert J\";i:9;s:13:\"TAYLOR, Ann E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCEMAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:150:\"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome : An androgen excess society guideline\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:17:\"Endocrine Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
